Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis

被引：19
作者：
Ceci, Francesco [1 ]
Castellucci, Paolo [1 ]
Mapelli, Paola [2 ]
Incerti, Elena [2 ]
Picchio, Maria [2 ]
Fanti, Stefano [1 ]
机构：
[1] Univ Bologna, S Orsola Malpighi Hosp, Serv Nucl Med, Bologna, Italy
[2] IRCCS San Raffaele Sci Inst, Nucl Med Serv, Milan, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
C-11-choline PET/CT; salvage radiotherapy; salvage lymph node dissection; PET-guided therapies; metastasis-directed therapies; LYMPH-NODE DISSECTION; SALVAGE RADIATION-THERAPY; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; F-18-FLUOROCHOLINE PET/CT; SURVIVAL; FAILURE; MEN; PREDICTS; IMPACT;
D O I：
10.2967/jnumed.115.170126
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The aim of this review is to report on the value of C-11-choline PET imaging as a diagnostic procedure for metastasis-directed therapies. Furthermore, the role of C-11-choline PET/CT as a diagnostic tool for monitoring castration-resistant prostate cancer patients treated with systematic therapy is assessed. Finally, the role of C-11-choline PET/CT in the prediction of survival in both castration-resistant prostate cancer patients and hormone-nave patients is investigated.
引用
收藏
页码：49S / 54S
页数：6
相关论文
共 49 条
  • [1] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Afshar-Oromieh, A.
    Malcher, A.
    Eder, M.
    Eisenhut, M.
    Linhart, H. G.
    Hadaschik, B. A.
    Holland-Letz, T.
    Giesel, F. L.
    Kratochwil, C.
    Haufe, S.
    Haberkorn, U.
    Zechmann, C. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 486 - 495
  • [2] Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth
    de Wit, Ronald
    Tannock, Ian
    Eisenberger, Mario
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (01) : 203 - 211
  • [3] Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status
    Azad, Arun A.
    Eigl, Bernhard J.
    Leibowitz-Amit, Raya
    Lester, Renee
    Kollmannsberger, Christian
    Murray, Nevin
    Clayton, Ravinder
    Heng, Daniel Y. C.
    Joshua, Anthony M.
    Chi, Kim N.
    [J]. EUROPEAN UROLOGY, 2015, 67 (03) : 441 - 447
  • [4] Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
    Berkovic, Patrick
    De Meerleer, Gert
    Delrue, Louke
    Lambert, Bieke
    Fonteyne, Valerie
    Lumen, Nicolaas
    Decaestecker, Karel
    Villeirs, Geert
    Vuye, Philippe
    Ost, Piet
    [J]. CLINICAL GENITOURINARY CANCER, 2013, 11 (01) : 27 - 32
  • [5] External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
    Bolla, Michel
    Van Tienhoven, Geertjan
    Warde, Padraig
    Dubois, Jean Bernard
    Mirimanoff, Rene-Olivier
    Storme, Guy
    Bernier, Jacques
    Kuten, Abraham
    Sternberg, Cora
    Billiet, Ignace
    Lopez Torecilla, Jose
    Pfeffer, Raphael
    Cutajar, Carmel Lino
    Van der Kwast, Theodore
    Collette, Laurence
    [J]. LANCET ONCOLOGY, 2010, 11 (11) : 1066 - 1073
  • [6] A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes
    Boorjian, Stephen A.
    Eastham, James A.
    Graefen, Markus
    Guillonneau, Bertrand
    Karnes, R. Jeffrey
    Moul, Judd W.
    Schaeffer, Edward M.
    Stief, Christian
    Zorn, Kevin C.
    [J]. EUROPEAN UROLOGY, 2012, 61 (04) : 664 - 675
  • [7] Natural history of surgically treated high-risk prostate cancer
    Briganti, Alberto
    Karnes, Robert Jeffrey
    Gandaglia, Giorgio
    Spahn, Martin
    Gontero, Paolo
    Tosco, Lorenzo
    Kneitz, Burkhard
    Chun, Felix K. H.
    Zaffuto, Emanuele
    Sun, Maxine
    Graefen, Markus
    Marchioro, Giansilvio
    Frohneberg, Detlef
    Giona, Simone
    Karakiewicz, Pierre I.
    Van Poppel, Hein
    Montorsi, Francesco
    Joniau, Steven
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (04) : 163.e7 - 163.e13
  • [8] Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?
    Castellucci, Paolo
    Ceci, Francesco
    Graziani, Tiziano
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Mazzarotto, Renzo
    Pettinato, Cinzia
    Celli, Monica
    Lodi, Filippo
    Fanti, Stefano
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (09) : 1424 - 1429
  • [9] Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
    Castellucci, Paolo
    Fuccio, Chiara
    Rubello, Domenico
    Schiavina, Riccardo
    Santi, Ivan
    Nanni, Cristina
    Allegri, Vincenzo
    Montini, Gian Carlo
    Ambrosini, Valentina
    Boschi, Stefano
    Martorana, Giuseppe
    Marzola, Maria Cristina
    Fanti, Stefano
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (01) : 55 - 63
  • [10] 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
    Ceci, Francesco
    Castellucci, Paolo
    Graziani, Tiziano
    Schiavina, Riccardo
    Renzi, Riccardo
    Borghesi, Marco
    Di Tullio, Piergiorgio
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Fanti, Stefano
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 84 - 91
12345